Nasal spray having dead sea salts
CA 2377088 A1 · Owner: Cordray, Scott · Inventors: Cordray, Scott
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A nasal spray formulation for use with the treatment of rhinitis sinusitis, epistaxis and post-surgical irrigation. The nasal spray formulation includes the Dead Sea salt or its equivalent. The composition of the Dead Sea salt mixture includes about 31-35 % magnesium halide about 24-26 % potassium , halide, about 4-8 % sodium halide about 0.4-0.6 % calcium halide, the halide being about 0.3-0.6 % bromide, about 99.4-99.7 % chloride and may also , include about 0.05-0.2 % sulphates about 0.5-0.2 % insolubles. The salts may comprise about 34-38 % water of crystallization. The spray formulation is about 0.5 to about 5 grams per liter of sterile aqueous solution contains a , buffer, and is …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 30, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 30, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 30, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.